eli lilly's tirzepatide is the leader in weight loss sector Lilly Trims Price of Popular Weight-Loss Drug on Its Site a Month After Trump Deal The CEO of Eli Lilly

The First Wave: Older GLP-1 Medications Before semaglutide stole the spotlight, several other GLP-1 agonists were used primarily for diabetes management, with modest weight loss benefits

Explore detailed information about tirzepatide treatment

Unlike Zepbound, which contains a single ingredient, CagriSemas two components cant be mixed together, requiring separate manufacturing and delivery via a dual-chambered pen

You tried semaglutide and plateaued

But they have some key differences

Semaglutide May Be Ideal If You: Prefer a more established, widely available option Are beginning your medical weight loss journey Want to test GLP-1 therapy before considering dual-action drugs Have moderate weight-related health concerns Tirzepatide May Be Ideal If You: Are struggling with more resistant weight Want the most advanced option available for fat reduction Have pre-diabetes, insulin resistance, or other metabolic concerns Did not see optimal results with GLP-1 therapy alone Safety and Side Effects Both medications are well-tolerated by most patients, though they can cause side effects such as: Nausea Fatigue Constipation or Diarrhea Mild injection site irritation The risk and intensity of side effects tend to be dose-dependent and usually subside as your body adjusts